Gano Kyle
Neurocrine Biosciences Inc ยท Chief Executive Officer
Gano Kyle is listed in public filings as director, officer: Chief Executive Officer. This Gano Kyle insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Neurocrine Biosciences Inc (NBIX). Investors use Gano Kyle's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $14M114.8k shares | Grant / ExerciseFeb 13, 2026 | $14.3M114.8k shares | $124.12 | -- | |
| $19M150.8k shares | Grant / ExerciseFeb 13, 2026 | $667.5K5.4k shares | $124.12 | -- | |
| --2.6k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable2.6k shares | -- | -- | |
| --4.5k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable2.2k shares | -- | -- | |
| --20.1k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable20.1k shares | -- | -- | |
| --156.2k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable10k shares | -- | -- | |
| $18M146.2k shares | Grant / ExerciseFeb 13, 2026 | $171.9K1.4k shares | $124.12 | -- | |
| $18M145k shares | Grant / ExerciseFeb 13, 2026 | $150.2K1.2k shares | $124.12 | -- |